PEPG · PepGen Inc.
$3.05
+0.14 (+4.81%)
At close · Aug 19
Market Cap
$209.86M
Shares
69.26M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.05
Open$2.98
Day$2.88–3.08
52W close$1.16–7.17
Avg vol 30d1.2M
Short int4.1M · 5.9% float · 6.1d
Short vol34%
Last earningsMar 30, 2026
DataMay 2022–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Mar 20, 2027
Est · unconfirmed
· in 30 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−19%
below
Price vs 50-day avg
+46%
above
RSI (14)
71
overbought
MACD trend
Positive
52-week position
31%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+59%
trailing
6-month return
−51%
trailing
YTD return
−53%
this year
Relative strength
−63%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-24% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.93% of float · ▼ -9.4% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
72 holders — mid 3-yr range
Squeeze score
67
elevated · 0–100
Fundamentals
EPS growth
+26%
Y/Y
Free cash flow
$-81.9M
Balance sheet
$60.5M
net cash
Quant / Vol
risk profile
Volatility
170%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
6.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−19%
Bearish
Price vs 50-day avg
+46%
Bullish
RSI (14)
71
Bearish
MACD trend
Positive
Bullish
52-week position
31%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-24% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.93% of float · ▼ -9.4% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
72 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $3 · 31%
Range high $7
vs 200-day avg -19%
vs 50-day avg +46%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PEPG
this stock
PepGen Inc.
|
$209.86M | -53.1% | — | — | 5.9% |
|
ONC
BeOne Medicines Ltd.
|
$535.83B | +24.0% | +22179.2% | 823.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.88B | +21.8% | +46.2% | 30.8 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$84.27B | +8.9% | +20.8% | 20.3 | 3.3% |
|
ARGX
Argenx SE
|
$61.75B | +22.8% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PEPG | +5.2% | +58.9% | -51.1% | +73.3% | -53.2% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +5.6% | +56.0% | -62.7% | +70.4% | -65.9% |
Key facts
CIK
1835597
CUSIP
713317105
13F (30d)
72 filings
72 filers
Visit website
Investor relations